88 related articles for article (PubMed ID: 24025600)
1. The DPP-4 inhibitor MK0626 and exercise protect islet function in early pre-diabetic kkay mice.
Li Y; Xiao J; Tian H; Pei Y; Lu Y; Han X; Liu Y; Zhong W; Sun B; Fang F; Shu H
Peptides; 2013 Nov; 49():91-9. PubMed ID: 24025600
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of dipeptidyl peptidase IV with sitagliptin (MK0431) prolongs islet graft survival in streptozotocin-induced diabetic mice.
Kim SJ; Nian C; Doudet DJ; McIntosh CH
Diabetes; 2008 May; 57(5):1331-9. PubMed ID: 18299314
[TBL] [Abstract][Full Text] [Related]
3. [Effects of Metformin and Sitagliptin on islet cell function in insulin-resistant prediabetic KKay mice].
Li P; Liang LL; Wang Y; Hou D; Yang X; Yang B
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2021 Nov; 37(6):644-649. PubMed ID: 34821099
[No Abstract] [Full Text] [Related]
4. Beneficial effects of vildagliptin combined with miglitol on glucose tolerance and islet morphology in diet-controlled db/db mice.
Ishibashi K; Hara A; Fujitani Y; Uchida T; Komiya K; Tamaki M; Abe H; Ogihara T; Kanazawa A; Kawamori R; Watada H
Biochem Biophys Res Commun; 2013 Nov; 440(4):570-5. PubMed ID: 24103756
[TBL] [Abstract][Full Text] [Related]
5. Improved outcome of islet transplantation in partially pancreatectomized diabetic mice by inhibition of dipeptidyl peptidase-4 with sitagliptin.
Kim YS; Oh SH; Park KS; No H; Oh BJ; Kim SK; Jung HS; Kim JH; Lee MS; Lee MK; Kim KW
Pancreas; 2011 Aug; 40(6):855-60. PubMed ID: 21747318
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy with a dipeptidyl peptidase-4 inhibitor and a proton pump inhibitor induces β-cell neogenesis from adult human pancreatic duct cells implanted in immunodeficient mice.
Suarez-Pinzon WL; Rabinovitch A
Cell Transplant; 2011; 20(9):1343-9. PubMed ID: 21396168
[TBL] [Abstract][Full Text] [Related]
7. DPP IV inhibitor suppresses STZ-induced islets injury dependent on activation of the IGFR/Akt/mTOR signaling pathways by GLP-1 in monkeys.
Zhang Y; Chen Y; Cheng J; Guo Z; Lu Y; Tian B
Biochem Biophys Res Commun; 2015 Jan; 456(1):139-44. PubMed ID: 25446112
[TBL] [Abstract][Full Text] [Related]
8. Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic beta-cell mass and function in a rodent model of type 2 diabetes.
Mu J; Woods J; Zhou YP; Roy RS; Li Z; Zycband E; Feng Y; Zhu L; Li C; Howard AD; Moller DE; Thornberry NA; Zhang BB
Diabetes; 2006 Jun; 55(6):1695-704. PubMed ID: 16731832
[TBL] [Abstract][Full Text] [Related]
9. Combined treatment of dipeptidyl peptidase-4 inhibitor and exercise training improves lipid profile in KK/Ta mice.
Tanimura Y; Aoi W; Mizushima K; Higashimura Y; Naito Y
Exp Physiol; 2019 Jul; 104(7):1051-1060. PubMed ID: 31020720
[TBL] [Abstract][Full Text] [Related]
10. DPP-4 inhibition improves glucose tolerance and increases insulin and GLP-1 responses to gastric glucose in association with normalized islet topography in mice with beta-cell-specific overexpression of human islet amyloid polypeptide.
Ahrén B; Winzell MS; Wierup N; Sundler F; Burkey B; Hughes TE
Regul Pept; 2007 Oct; 143(1-3):97-103. PubMed ID: 17482289
[TBL] [Abstract][Full Text] [Related]
11. Effects of DPP-4 inhibition on cardiac metabolism and function in mice.
Lenski M; Kazakov A; Marx N; Böhm M; Laufs U
J Mol Cell Cardiol; 2011 Dec; 51(6):906-18. PubMed ID: 21871459
[TBL] [Abstract][Full Text] [Related]
12. The Chinese patent medicine, Jin-tang-ning, ameliorates hyperglycemia through improving β cell function in pre-diabetic KKAy mice.
Liu SN; Liu Q; Lei L; Sun SJ; Li CN; Huan Y; Hou SC; Shen ZF
Chin J Nat Med; 2020 Nov; 18(11):827-836. PubMed ID: 33308603
[TBL] [Abstract][Full Text] [Related]
13. Combined treatment with a dipeptidyl peptidase-IV inhibitor (sitagliptin) and an angiotensin II type 1 receptor blocker (losartan) promotes islet regeneration via enhanced differentiation of pancreatic progenitor cells.
Liang J; Leung KK; Lam SY; Leung PS
Diabetes Obes Metab; 2012 Sep; 14(9):842-51. PubMed ID: 22519909
[TBL] [Abstract][Full Text] [Related]
14. MK-626, a dipeptidyl peptidase-4 inhibitor, does not improve the hyperglycemia or hyperinsulinemia of nonobese diabetic MKR mice.
Bhattacharjee A; Allister EM; Wheeler MB
Can J Physiol Pharmacol; 2012 May; 90(5):663-8. PubMed ID: 22530993
[TBL] [Abstract][Full Text] [Related]
15. [The relationship between mTor/S6K1 signaling pathway and insulin resistance and the study of aerobic exercise on this pathway].
Niu YM; Yuan H; Zhang N; Fu L
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2010 Nov; 26(4):399-403. PubMed ID: 21328971
[TBL] [Abstract][Full Text] [Related]
16. Dipeptidyl peptidase-4 inhibitor ameliorates early renal injury through its anti-inflammatory action in a rat model of type 1 diabetes.
Kodera R; Shikata K; Takatsuka T; Oda K; Miyamoto S; Kajitani N; Hirota D; Ono T; Usui HK; Makino H
Biochem Biophys Res Commun; 2014 Jan; 443(3):828-33. PubMed ID: 24342619
[TBL] [Abstract][Full Text] [Related]
17. Small molecule inhibition of dipeptidyl peptidase-4 enhances bone marrow progenitor cell function and angiogenesis in diabetic wounds.
Whittam AJ; Maan ZN; Duscher D; Barrera JA; Hu MS; Fischer LH; Khong S; Kwon SH; Wong VW; Walmsley GG; Giacco F; Januszyk M; Brownlee M; Longaker MT; Gurtner GC
Transl Res; 2019 Mar; 205():51-63. PubMed ID: 30452888
[TBL] [Abstract][Full Text] [Related]
18. Dipeptidyl peptidase-4 inhibitors and preservation of pancreatic islet-cell function: a critical appraisal of the evidence.
van Genugten RE; van Raalte DH; Diamant M
Diabetes Obes Metab; 2012 Feb; 14(2):101-11. PubMed ID: 21752172
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of type 2 diabetes mellitus in the male Zucker diabetic fatty rat: the effects of stress and non-volitional exercise.
Király MA; Bates HE; Yue JT; Goche-Montes D; Fediuc S; Park E; Matthews SG; Vranic M; Riddell MC
Metabolism; 2007 Jun; 56(6):732-44. PubMed ID: 17512304
[TBL] [Abstract][Full Text] [Related]
20. Isosteviol increases insulin sensitivity and changes gene expression of key insulin regulatory genes and transcription factors in islets of the diabetic KKAy mouse.
Nordentoft I; Jeppesen PB; Hong J; Abudula R; Hermansen K
Diabetes Obes Metab; 2008 Sep; 10(10):939-49. PubMed ID: 18201205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
